Polomar Health Services (PMHS) Cash & Equivalents (2022 - 2026)
Polomar Health Services' Cash & Equivalents came in at $178,872 for Q2 2026, compared with $4,678 a year earlier and up 103.7% from the prior quarter.
Analysis
Polomar Health Services (PMHS) Cash & Equivalents (2022 - 2026) Analysis & Trends
At the end of FY2025, Polomar Health Services' Cash & Equivalents was $132,150.
- Cash & Equivalents carries a three-year compound annual growth rate of -16.3% (FY2022 to FY2025).
- Going back by year, Cash & Equivalents was $6,191 in FY2024 (-29.7%), $8,808 in FY2023 (-96.1%) and $225,619 in FY2022.
- The Q2 2026 figure represents the highest quarterly Cash & Equivalents since Q1 2023.
- Year-over-year, Cash & Equivalents increased in two of the last six quarters, with growth averaging 51.3%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q3 2023 (growth of 693.8%), and the weakest in Q4 2023 (a decline of 96.1%).
- Business Quant data shows PMHS's Cash & Equivalents at $87,818 (Q1 2026), $132,150 (Q4 2025) and $38,854 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Polomar Health Services | 4.81 Mn | 4.37 Mn | 935,916.00 | 178,872.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 178,872.00 |
| Mar 31, 2026 | 87,818.00 |
| Dec 31, 2025 | 132,150.00 |
| Sep 30, 2025 | 38,854.00 |
| Jun 30, 2025 | 4,678.00 |
| Mar 31, 2025 | 129,331.00 |
| Dec 31, 2024 | 6,191.00 |
| Sep 30, 2024 | 16,202.00 |
| Jun 30, 2024 | 19,857.00 |
| Mar 31, 2024 | 27,993.00 |
| Dec 31, 2023 | 8,808.00 |
| Sep 30, 2023 | 36,546.00 |
| Jun 30, 2023 | 28,019.00 |
| Mar 31, 2023 | 198,335.00 |
| Dec 31, 2022 | 225,619.00 |
| Sep 30, 2022 | 4,604.00 |
API Access
Polomar Health Services Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PMHS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PMHS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PMHS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();